[en] In our previous study, we reported the interesting in vitro antiplasmodial activity of some Rwandan plant extracts. This gave rise to the need for these extracts to also be evaluated in vivo and to identify the compounds responsible for their antiplasmodial activity. The aim of our study was, on the one hand, to evaluate the antiplasmodial activity in vivo and the safety of the selected Rwandan medicinal plants used in the treatment of malaria, with the objective of promoting the development of improved traditional medicines and, on the other hand, to identify the active ingredients in the plants. Plant extracts were selected according to their selectivity index. The in vivo antiplasmodial activity of aqueous, methanolic, and dichloromethane extracts was then evaluated using the classical 4-day suppressive test on Plasmodium berghei infected mice. The activity of the plant extracts was estimated by measuring the percentage of parasitemia reduction, and the survival of the experimental animals was recorded. A bioguided fractionation was performed for the most promising plants, in terms of antiplasmodial activity, in order to isolate active compounds identified by means of spectroscopic and spectrometric methods. The highest level of antiplasmodial activity was observed with the methanolic extract of Fuerstia africana (> 70 %) on days 4 and 7 post-treatment after intraperitoneal injection and on day 7 using oral administration. After oral administration, the level of parasitemia reduction observed on day 4 post-infection was 44 % and 37 % with the aqueous extract of Terminalia mollis and Zanthoxylum chalybeum, respectively. However, the Z. chalybeum extract presented a high level of toxicity after intraperitoneal injection, with no animals surviving on day 1 post-treatment. F. africana, on the other hand, was safer with 40 % mouse survival on day 20 post-treatment. Ferruginol is already known as the active ingredient in F. Africana, and ellagic acid (IC50 = 175 ng/mL) and nitidine (IC50 = 77.5 ng/mL) were identified as the main active constituents of T. mollis and Z. chalybeum, respectively. F. africana presented very promising antiplasmodial activity in vivo. Although most of the plants tested showed some level of antiplasmodial activity, some of these plants may be toxic. This study revealed for the first time the role of ellagic acid and nitidine as the main antimalarial compounds in T. mollis and Z. chalybeum, respectively.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Muganga, Raymond
Angenot, Luc ; Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Tits, Monique ; Université de Liège - ULiège > Département de pharmacie > Phytochimie et phytothérapie
Frederich, Michel ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Language :
English
Title :
In Vitro and In Vivo Antiplasmodial Activity of Three Rwandan Medicinal Plants and Identification of Their Active Compounds
Publication date :
2014
Journal title :
Planta Medica
ISSN :
0032-0943
eISSN :
1439-0221
Publisher :
Georg Thieme Verlag Stuttgart, New York, United States - New York
WHO World malaria report 2011. Geneva World Health Organization: 2011
Ginsburg H., Deharo E. A call for using natural compounds in the development of new antimalarial treatments - an introduction. Malar J: 2011; 10 S1
Rasoanaivo P., Wright C. W., Willcox M. L., Gilbert B. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malar J: 2011; 10 S4
Muganga R., Angenot L., Tits M., Frédérich M. Antiplasmodial and cytotoxicity of Rwandan medicinal plants used in the treatment of malaria. J Ethnopharmacol: 2010; 128 52 57
Koch A., Orljala J., Mutiso P. C., Soejarto D. D. An antimalarial abietane diterpene from Fuerstia africana T.C.E. Fries. Biochem Syst Ecol: 2006; 34 270 272
Pinmai K., Hiriote W., Soonthornchareonnon N., Jongsakul K., Sireeratawong S., Tor-Udom S. In vitro and in vivo antiplasmodial activity and cytotoxicity of water extracts of Phyllanthus emblica, Terminalia chebula, and Terminalia bellerica. J Med Assoc Thai: 2010; 93 S120 S126
Rukunga G. M., Gathirwa J. W., Omar S. A., Muregi F. W., Muthaura C. N., Kirira P. G., Mungai G. M., Kofi-Tsekpo W. M. Anti-plasmodial activity of the extracts of some Kenyan medicinal plants. J Ethnopharmacol: 2009; 121 282 285
Ramanandraibe V., Grellier P., Martin M. T., Deville A., Joyeau R., Ramanitrahasimbola D., Mouray E., Rasoanaivo P., Mambu L. Antiplasmodial phenolic compounds from Piptadenia pervillei. Planta Med: 2008; 74 417 421
Bulus T., Atawodi S. E., Mamman M. Acute toxicity of aqueous extract of Terminalia mollis on rats. ChemClass Journal: 2007; 4 57 60
Mbwambo Z. H., Moshi M. J., Masimba P. J., Kapingu M. C., Nondo R. SO. Antimicrobial activity and brine shrimp toxicity of extracts of Terminalia brownii roots and stem. BMC Complem Altern M: 2007; 7 9
Oelrichs P. B., Pearce C. M., Zhu J., Filippich L. J. Isolation and structure determination of terminalin a toxic condensed tannin from Terminalia oblongata. Nat Toxins: 1994; 2 144 150
Lacaille-Dubois M. A., Wagner H. A review of the biological and pharmaceutical activities of saponins. Phytomedicine: 1996; 4 363 386
Simões-Pires C. A., Vargas S., Marston A., Ioset J. R., Paulo M. Q., Matheeussen A., Maes L. Ellagic acid derivatives from Syzygium cumini stem bark: investigation of their antiplasmodial activity. Nat Prod Commun: 2009; 4 1371 1376
Soh N. P., Witkowski B., Olagnier D., Nicolau M. L., Garcia-Alvarez M. C., Berry A., Vical B. In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob Agents Chemother: 2009; 53 1100 1106
Clifford M. N., Scalbert A. Ellagitannins - nature, and dietary burden. J Sci Food Agr: 2000; 80 1118 1125
Reddy M. K., Cupta S. K., Jacob M. R., Khan S. I., Ferreira D. Antioxidant, antimalaria and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum. Planta Med: 2007; 73 461 467
Asres K., Bucar F., Knauder E., Yardley V., Kendrick H., Croft S. L. In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytother Res: 2001; 15 613 617
Wilson T. C., Hagerman A. Quantitative determination of ellagicacid. J Agric Food Chem: 1990; 38 1678 1683
Haslam E. Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J Nat Prod: 1996; 59 205 215
Chen P. S., Li J. H., Liu T. Y., Lin T. C. Folk medicine Terminalia catappa and its major tannin component, punicalagin, are effective against bleomycin-induced genotoxicity in Chinese hamster ovary cells. Cancer Lett: 2000; 152 115 122
Kulkarni A. P., Mahal H S., Kapoor S., Aradhya S. M. In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin. J Agric Food Chem: 2007; 55 1491 1500
Haidari M., Ali M., Ward Casscells I. II, Madjid M. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine: 2009; 16 1127 1136
Lin C. C., Hsu Y. F., Lin T. C., Hsu H. Y. Antioxidant and hepatoprotective effect of punicalagin and punicalin on acetaminophen-induced liver damage in rats. Phytotherapy Research: 2001; 15 206 212
Filippich L. J., Zhu J., Alsalami M. T. Hepatotoxicity and nephrotoxic principles in Terminalia oblongata. Res Vet Sci: 1991; 50 170 177
Cerda B., Ceron J. J., Barberan A. T., Espin J. C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Food Chem: 2003; 51 3493 3501
Dell'Agli M., Parapini S., Basilico N., Verotta L., Taramelli D., Berry C., Bosisio E. In vitro studies of the mechanism of action of two compounds with antiplasmodial activity. Planta Med: 2003; 69 162 164
Egan T. J., Marques H. M. The role of haem in the activity of chloroquine and related antimalarial drugs. Coordin Chem Rev: 1999; 190-192 493 517
Hamad A. WR, Al-Momani W. M., Janakat S., Oran S. A. Bioavailability of ellagic acid after single dose administration using HPLC. Pakistan Journal of Nutrition: 2009; 8 1661 1664
Kaur S., Grover I. S., Kumar S. Antimutagenic potential of ellagic acid isolated from Terminalia arjuna. Indian J Exp Biol: 1997; 35 478 482
Kasimsetty S. G., Bialonska D., Reddy M. K., Ma G., Khan I., Ferreira D. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J Agric Food Chem: 2010; 58 2180 2187
Rogerio A. P., Fontanari C., Borducchi E., Keller A. C., Russo M., Soares E. G., Albuquerque D. A., Faccioli L. H. Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. Eur J Pharmacol: 2008; 580 262 270
Ruibal J. I. Duplication inhibition of the human immunideficiency virus by tannin extracts from Pinus caribaea morelet. J Pharmacol: 2003; 2 37
Dell'Agli M., Galli G. V., Bulgari M., Basilico N., Romeo S., Bhattacharya D., Taramelli D., Bosisio E. Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria. Malar J: 2010; 9 208
Lakovleva L. V., Ivakhnenko A. K., Buniatian N. D. The protective action of ellagic acid in experimental myocarditis. Eksp Klin Farmakol: 1998; 61 31 34
Beserra A. M., Calegari P. I., Souza Mdo C., Dos Santos R. A., Lima J. C., Silva R. M., Balogun S. O., Martins D. T. Gastroprotective and ulcer-healing mechanism of ellagic acid in experimental rats. J Agric Food Chem: 2011; 59 6957 6965
Singh K., Khanna A. K., Chander R. Hepatoprotective effect of ellagic acid against carbon induced hepatotoxicity in rats. Indian J Exp Biol: 1999; 37 1025 1026
Neuwinger H. D. Afrikanische Arzneipflanzen und Jagdgifte. Stuttgart Wissenschaftliche Verlagsgesellschaft mbH: 1998; 822 827
Yasumoto T., Endo M. Toxicity study on a marine snail Turbo argyrostoma. III. Occurrence of candicine. Nippon Suisan Gakkaishi: 1974; 40 841 845
Hori K., Yamamoto T., Miyazawa K., Ito K. Occurrence of candicine o-sulfatei in the red alga, Ahnfeltia paradoxa. B Jpn Soc Sci Fish: 1980; 46 559 562
Nakanishi T., Suzuki M., Mashiba A., Ishikawa K., Yokotsuka T. Synthesis of NK 109, an anticancer Benzo[c]phenanthridine alkaloid. J Org Chem: 1998; 63 4235 4239
Liang M., Zhang W., Hu J., Runhui L., Zhang C. Simultaneaous analysis of alkaloids from Zanthoxylum nitidum by high performance liquide chromatography-diode array detector-electrospray tandem mass spectrometry. J Pharm Biomed Anal: 2006; 42 178 183
Talontsi F. M., Matasyoh J. C., Ngoumfo R. M., Chepkorir R. Mosquito larvicidal activity of alkaloids from Zanthoxylum lemairei against the malaria vector Anopheles gambiae. Pestic Biochem Phys: 2011; 99 82 85
Gakunju D. M., Mberu E. K., Dossaji S. F., Gray A. I., Waigh R. D., Waterman P. G., Watkins W. M. Potent antimalarial activity of the alkaloid nitidine, isolated from a Kenyan herbal remedy. Antimicrob Agents Chemother: 1995; 39 2606 2609
Bouquet J., Rivaud M., Chevalley S., Deharo E., Jullian V., Valentin A. Biological activities of nitidine, a potential anti-malarial lead compound. Malar J: 2012; 11 67
Kato A., Masataka M., Ichimaru M., Nishiyama Y. Isolation of alkaloidal constituents of Zanthoxylum usambarense and Zanthoxylum chalybeum using ion-pair HPLC. J Nat Prod: 1996; 59 316 318
Tan G. T., Pezzuto J. M., Kinghorn A. D., Hughes S. H. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J Nat Prod: 1991; 54 143 154
Zirihi G. N., N'Guessan K., Etien D. T., Serikouassi B. Evaluation in vitro of antiplasmodial activity of ethanolic extracts of Funtumia elastica, Rauvolfia vomitoria and Zanthoxylum gilletii on Plasmodium falciparum isolates from Côte d'Ivoire. J Anim Plant Sci: 2009; 5 406 413
Fidock D. A., Rosenthal P. J., Croft S. L., Brun R., Nwaka S. Antimalaria drug discovery: efficicacy models for compound screening. Nat Rev Drug Discov: 2004; 3 509 520
Frédérich M., De Pauw M. C., Prosperi C., Tits M., Brandt V., Penelle J., Hayette M. P., De Mol P., Angenot L. Strychnogucines A and B, two new antiplasmodial bisindole alkaloids from Strychnos icaja. J Nat Prod: 2001; 64 12 16